Skip to main content

Nonprofit · EIN 81-5164082

PANCREATIC CANCER CURE FOUNDATION

Tax-exempt · QUAKERTOWN, PA 18951

Financials

$70K$80K2022$78K$73K2023$90K$88K2024
Revenue Expenses · by fiscal year end
Financials of PANCREATIC CANCER CURE FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
September 30, 2025990$89,726$88,179$1,547$7,971$0$7,971
September 30, 2024990$77,645$73,144$4,501$6,424$0$6,424
September 30, 2023990$69,855$79,533-$9,678$1,923$0$1,923
Financial details: 990 for the year ended September 30, 2025

Revenue

Contributions, gifts and grants
$89,385
Program service revenue
$0
Investment income
$36
Net income from fundraising events
$305
Other revenue
$305

Expenses

Grants and similar amounts paid
$80,000
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Accounting fees
$1,905
Program services (functional)
$80,000
Management and general (functional)
$8,179

Balance sheet and other

Total assets, start of year
$6,424
Total assets, end of year
$7,971
Total liabilities, end of year
$0
Net assets, end of year
$7,971
Net assets without donor restrictions
$7,971
Gross receipts
$110,476
Employees
0
Volunteers
60
Year formed
2016
State of legal domicile
PA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended September 30, 2025, highest compensation first.

NameTitleHours / weekCompensation
MICHAEL CYGANDIRECTOR
Trustee or director
5$0
ANTHONY CYGANVICE PRESIDENT
Trustee or director, Officer
3$0
DAVID CYGANSECRETARY
Trustee or director, Officer
5$0
JANE CYGANTREASURER
Trustee or director, Officer
10$0
STEPHEN CYGANPRESIDENT
Trustee or director, Officer
3$0
NATHAN CYGANDIRECTOR
Trustee or director
3$0
GREGORY CYGANDIRECTOR
Trustee or director
4$0
MARLENE MAYZADIRECTOR
Trustee or director
3$0
CELESTE VAUGHNDIRECTOR
Trustee or director
8$0
LAURA DEPENBUSCHDIRECTOR
Trustee or director
8$0
990 for the year ended September 30, 2024: 10 people
NameTitleHours / weekCompensation
MICHAEL CYGANDIRECTOR
Trustee or director
5$0
ANTHONY CYGANVICE PRESIDENT
Trustee or director, Officer
3$0
DAVID CYGANSECRETARY
Trustee or director, Officer
5$0
JANE CYGANTREASURER
Trustee or director, Officer
10$0
STEPHEN CYGANPRESIDENT
Trustee or director, Officer
3$0
NATHAN CYGANDIRECTOR
Trustee or director
3$0
GREGORY CYGANDIRECTOR
Trustee or director
4$0
MARLENE MAYZADIRECTOR
Trustee or director
3$0
CELESTE VAUGHNDIRECTOR
Trustee or director
8$0
LAURA DEPENBUSCHDIRECTOR
Trustee or director
8$0
990 for the year ended September 30, 2023: 10 people
NameTitleHours / weekCompensation
MICHAEL CYGANDIRECTOR
Trustee or director
5$0
ANTHONY CYGANVICE PRESIDENT
Trustee or director, Officer
3$0
DAVID CYGANSECRETARY
Trustee or director, Officer
5$0
JANE CYGANTREASURER
Trustee or director, Officer
10$0
STEPHEN CYGANPRESIDENT
Trustee or director, Officer
3$0
NATHAN CYGANDIRECTOR
Trustee or director
3$0
GREGORY CYGANDIRECTOR
Trustee or director
4$0
MARLENE MAYZADIRECTOR
Trustee or director
3$0
CELESTE VAUGHNDIRECTOR
Trustee or director
8$0
LAURA DEPENBUSCHDIRECTOR
Trustee or director
8$0

Address and contacts

Address (IRS master file)
CO ANTHONY CYGAN 251 S 5TH STREET, QUAKERTOWN, PA 18951-0000
In care of
% MICHAEL CYGAN
Principal officer (990 for 2024)
STEPHEN CYGAN, 1545 W LEESPORT ROAD, LEESPORT, PA 19533
Signed the 990
ANTHONY CYGAN, VICE PRESIDENT
Phone
(215) 783-0502
Return prepared by
STYER ASSOCIATES PC

Mission

PANCREATIC CANCER CURE FOUNDATION'S MISSION IS TO RAISE MONEY AND DISTRIBUTE FUNDING PRIMARILY TOWARDS PANCREATIC CANCER RESEARCH AND COMPASSIONATE CARE INITIATIVES, AND, TO A LESSER EXTENT, AWARENESS AND ADVOCACY EFFORTS.

990 for the year ended September 30, 2025

Program accomplishments

  • $34,500 IN FUNDING WAS PROVIDED TO SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. $32,500 OF THAT AMOUNT WAS SPECIFICALLY DIRECTED TO THE PANCREAS, BILIARY & RELATED RESEARCH CENTER TO SUPPORT RESEARCH. THE SUPPORTED RESEARCH INCLUDES SEEKING IMPROVEMENTS TO EARLY DETECTION OF PANCREATIC CANCER AND TO DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. THE REMAINING $2,000 OF THIS FUNDING WAS USED FOR JEFFERSON'S "COMPASSIONATE CARE" INITIATIVES SUPPORTING PANCREATIC CANCER PATIENTS DURING TREATMENT.
    Expenses $34,500 · grants $34,500
  • $31,500 WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO BE DIRECTED TO THE MARVIN & CONCETTA GREENBERG PANCREATIC CANCER INSTITUTE AT FOX CHASE. THIS FUNDING SUPPORTS MULTI-DISCIPLINARY RESEARCH CURRENTLY BEING CONDUCTED IN KEY AREAS, SUCH AS TUMOR MICROENVIRONMENT & FIBROBLAST SIGNALING, CANCER METABOLISM, CLINCIAL TRIALS & NEOADJUVANT THERAPY, AND POPULATION SCIENCES WHICH ANALYZE CULTURAL, BEHAVIORAL, GENETIC AND ENVIRONMENTAL FACTORS THAT COULD BE USED TO TAILOR TREATMENTS AND SUPPORT COMMUNITY OUTREACH.
    Expenses $31,500 · grants $31,500
  • $10,000 WAS PROVIDED TO UPLIFTING ATHLETES 2025 YOUNG INVESTIGATOR PROGRAM PROVIDING THE BASIS FOR A MATCHING GRANT BY THE UPLIFTING ATHLETES ORGANIZATION. THIS MATCHING GRANT BASIS WAS COMBINED WITH PCCF NOMINATION OF DR. JAYE GARDINER FOR THE YOUNG INVESTIGATOR GRANT SELECTION OF WHICH ONLY 10 RECIPIENTS ARE SELECTED NATIONALLY EACH YEAR. THE AGGREGATE FUNDING (PCCF BASE AND UPLIFTING ATHLETES MATCH) WILL ALLOW DR. GARDINER TO CONTINUE THE RESEARCH SHE INITIATED AT THE MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE AT FOX CHASE CANCER CENTER WHERE SHE FOCUSES ON THE TUMOR MICROENVIRONMENT (TME) AND HOW TME PLAYS A KEY ROLE IN THE GROWTH OF TUMORS IN PANCREATIC ADENOCARCINOMA.
    Expenses $10,000 · grants $10,000
  • $4,000 WAS PROVIDED TO ST. LUKE'S CANCER CENTER FOR "COMPASSIONATE CARE" DISTRIBUTION TO FINANCIALLY COMPROMISED PANCREATIC CANCER PATIENTS PROVIDING SUPPORT TO COVER COSTS SUCH AS TRANSPORTATION, UTILITIES, ETC. DURING TREATMENT.
    Expenses $4,000 · grants $4,000

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in September, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025September 30, 2026February 16, 2027Not due yet
2024September 30, 2025February 17, 2026990 on file
2023September 30, 2024February 18, 2025990 on file

IRS record

EIN
81-5164082
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2018
Accounting year ends
September
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H11)
Assets (IRS master file)
$7,971
Income (IRS master file)
$110,476

Filing history

FormYear endedRevenueExpensesAssetsReturn
990September 2025$89,726$88,179$7,971XML
990September 2024$77,645$73,144$6,424XML
990September 2023$69,855$79,533$1,923XML
990September 2022$79,330$76,672$11,601IRS
990September 2021–––IRS
990September 2020–––IRS
990September 2019–––IRS
990September 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 81-5164082).

Questions about PANCREATIC CANCER CURE FOUNDATION

What is the EIN of PANCREATIC CANCER CURE FOUNDATION?
The employer identification number (EIN) of PANCREATIC CANCER CURE FOUNDATION is 81-5164082.
Is PANCREATIC CANCER CURE FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2018.
Are donations to PANCREATIC CANCER CURE FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does PANCREATIC CANCER CURE FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of PANCREATIC CANCER CURE FOUNDATION due?
The return for tax year 2025 (the year ending September 30, 2026) is due February 16, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did PANCREATIC CANCER CURE FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended September 2025.
Who is the principal officer of PANCREATIC CANCER CURE FOUNDATION?
The 990 for the year ended September 30, 2025 names STEPHEN CYGAN.
Who are the officers and directors of PANCREATIC CANCER CURE FOUNDATION?
The 990 for the year ended September 30, 2025 lists 10 people; 0 received compensation from the organization.
How much revenue does PANCREATIC CANCER CURE FOUNDATION have?
On its 990 for the year ended September 30, 2025 it reported revenue of $89,726, expenses of $88,179 and total assets of $7,971 at year end.

Other nonprofits in QUAKERTOWN

All nonprofits in QUAKERTOWN · Pennsylvania · Medical research